BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34045534)

  • 1. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Kunadirek P; Ariyachet C; Sriphoosanaphan S; Pinjaroen N; Sirichindakul P; Nookaew I; Chuaypen N; Tangkijvanich P
    Sci Rep; 2021 May; 11(1):11201. PubMed ID: 34045534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Analyses Reveal Long Non-Coding RNA in Peripheral Blood Mononuclear Cells as a Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma.
    Kunadirek P; Pinjaroen N; Nookaew I; Tangkijvanich P; Chuaypen N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
    Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
    J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence.
    Yan P; Huang Z; Mou T; Luo Y; Liu Y; Zhou B; Cao Z; Wu Z
    BMC Cancer; 2021 Apr; 21(1):436. PubMed ID: 33879119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis.
    Lei B; Zhou J; Xuan X; Tian Z; Zhang M; Gao W; Lin Y; Ni B; Pang H; Fan W
    Cancer Med; 2019 Apr; 8(4):1423-1433. PubMed ID: 30714679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 10. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma.
    Zhang Y; Tang Y; Guo C; Li G
    Aging (Albany NY); 2021 May; 13(9):12865-12895. PubMed ID: 33946043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
    Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma.
    Poortahmasebi V; Nejati A; Abazari MF; Nasiri Toosi M; Ghaziasadi A; Mohammadzadeh N; Tavakoli A; Khamseh A; Momenifar N; Gholizadeh O; Norouzi M; Jazayeri SM
    Can J Gastroenterol Hepatol; 2022; 2022():9541600. PubMed ID: 35265561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
    Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
    Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma.
    Li S; Huang J; Yang F; Zeng H; Tong Y; Li K
    Sci Rep; 2021 May; 11(1):11078. PubMed ID: 34040099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.